Abstract
To evaluate the role of 2-deoxy-2-(F)fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) for selecting patients with extensive ovarian cancer (OC) for neoadjuvant chemotherapy by evaluating predictors of overall survival in patients with stage IIIC/IV OC.
| Original language | English |
|---|---|
| Journal | International Journal of Gynecological Cancer |
| Volume | 22 |
| Issue number | 7 |
| Pages (from-to) | 1163-9 |
| Number of pages | 7 |
| ISSN | 1048-891X |
| DOIs | |
| Publication status | Published - 2012 |
Fingerprint
Dive into the research topics of 'Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS